Drug Profile
IMX 101
Alternative Names: H. pylori vaccine - ImevaX; Helicobacter pylori vaccine - ImevaX; IMX101Latest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator ImevaX
- Class Bacterial vaccines; Helicobacter pylori eradication therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Helicobacter infections
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for phase-I development in Helicobacter-infections in Germany (Intradermal)
- 28 Feb 2020 No recent reports of development identified for phase-I development in Helicobacter-infections in Germany (Sublingual)
- 23 Dec 2018 ImevaX completes a phase I trial in Helicobacter infections in Germany (Sublingual, Intradermal) (NCT03270800)